1. Home
  2. LRE vs VVOS Comparison

LRE vs VVOS Comparison

Compare LRE & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lead Real Estate Co. Ltd

LRE

Lead Real Estate Co. Ltd

HOLD

Current Price

$1.30

Market Cap

20.5M

Sector

N/A

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$2.14

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRE
VVOS
Founded
2001
2016
Country
Japan
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.5M
19.4M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
LRE
VVOS
Price
$1.30
$2.14
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
17.5K
122.1K
Earning Date
01-01-0001
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
32.27
N/A
EPS
0.43
N/A
Revenue
$130,601,512.00
$17,317,000.00
Revenue This Year
N/A
$17.96
Revenue Next Year
N/A
$55.64
P/E Ratio
$3.04
N/A
Revenue Growth
N/A
18.76
52 Week Low
$1.00
$1.98
52 Week High
$2.97
$7.95

Technical Indicators

Market Signals
Indicator
LRE
VVOS
Relative Strength Index (RSI) 51.21 40.41
Support Level $1.25 $1.98
Resistance Level $1.29 $2.28
Average True Range (ATR) 0.06 0.13
MACD 0.02 0.03
Stochastic Oscillator 100.00 42.86

Price Performance

Historical Comparison
LRE
VVOS

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: